Short answer · Medically reviewed summary · Last updated: 2026-04-07
Microphthalmia is a rare congenital condition where one or both eyeballs are abnormally small and underdeveloped at birth. This condition can significantly impact visual acuity and is often associated with other developmental anomalies of the eye, requiring a multidisciplinary approach for management. What exactly is Microphthalmia and how does it affect the body? Microphthalmia is characterized by a globe that is structurally smaller than average, typically defined by a total axial length of the eye that is at least two standard deviations below the mean for the patient's age.
Microphthalmia is a rare congenital condition where one or both eyeballs are abnormally small and underdeveloped at birth. This condition can significantly impact visual acuity and is often associated with other developmental anomalies of the eye, requiring a multidisciplinary approach for management.
Microphthalmia is characterized by a globe that is structurally smaller than average, typically defined by a total axial length of the eye that is at least two standard deviations below the mean for the patient's age. While the primary effect is on the eye, Microphthalmia often occurs as part of a broader syndrome involving other body systems, such as the central nervous system, skeletal structure, or kidneys. Because the eye does not develop to its full size, individuals often experience varying degrees of vision loss, ranging from mild impairment to complete blindness, depending on the severity of the developmental arrest.
Clinicians generally categorize Microphthalmia based on the underlying anatomy and associated features. It is frequently discussed alongside anophthalmia (the complete absence of eye tissue), as they share similar developmental origins. The main classifications include:
Microphthalmia is a rare condition with a global prevalence estimated to be approximately 1 in 7,000 to 1 in 10,000 live births. It is a congenital condition, meaning it is present at birth. There is no significant bias toward gender or specific geographic regions, though certain genetic mutations associated with Microphthalmia may appear more frequently in populations with higher rates of consanguinity. At DiseaseMaps.org, we are building a community for those affected; currently, 3 people with Microphthalmia have joined to share their lived experiences and connect with others navigating this rare diagnosis.
The development of Microphthalmia occurs during early pregnancy, usually between the fourth and seventh weeks of gestation. It is caused by a disruption in the complex genetic signaling pathways responsible for eye formation. While many cases are linked to mutations in specific genes—such as SOX2, OTX2, or PAX6—environmental factors, including prenatal infections (like rubella or CMV) or exposure to certain teratogenic substances, can also interfere with normal ocular development.
It is important to distinguish Microphthalmia from conditions like nanophthalmos, where the eye is small but structurally normal, or from simple refractive errors like high hyperopia (farsightedness). Unlike common vision problems that can be corrected with glasses, Microphthalmia involves structural underdevelopment of the ocular tissues themselves, which often necessitates specialized ocular prosthetics or complex surgical interventions.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.